Evidence map›Paper›PMID 33583771›Full record

ReviewMolecular & cellular proteomics : MCP2021

A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry-Based Glycoproteomics.

Nicholas M Riley, Carolyn R Bertozzi, Sharon J Pitteri

Abstract readReview
In one paragraph

Review in Molecular & cellular proteomics : MCP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Site-specific O-glycans influence lacritin structure and multimerization in tears.Protein science : a publication of the Protein Society · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. UnderstandingJournal of the American Society for Mass Spectrometry · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Glycan Sequencing, A Brief Primer.Glycoscience & therapy · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nicholas M RileyDepartment of Chemistry, Stanford University, Stanford, California, USA. Electronic address: nmriley@stanford.edu.
Carolyn R BertozziDepartment of Chemistry, Stanford University, Stanford, California, USA; Howard Hughes Medical Institute, Stanford, California, USA.
Sharon J PitteriDepartment of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University School of Medicine, Palo Alto, California, USA. Electronic address: spitteri@stanford.edu.

Funding

Stanford Molecular and Cellular Characterization LaboratoryU01CA196387 · NCI · STANFORD UNIVERSITY · PI BROOKS, JAMES D. · 2015 to 2020
$5.2M
Investigating the Surface GlycoproteomeR01CA200423 · NCI · STANFORD UNIVERSITY · PI Carolyn Bertozzi · 2015 to 2026
$3.8M
Glycosylation and Immune Evasion in Urologic TumorsU01CA226051 · NCI · STANFORD UNIVERSITY · PI BERTOZZI, CAROLYN, BROOKS, JAMES D. · 2019 to 2023
$3.0M
Making glycoproteomics via mass spectrometry more accessible to the greater scientific communityU01CA207702 · NCI · STANFORD UNIVERSITY · PI BERTOZZI, CAROLYN, PITTERI, SHARON · 2016 to 2019
$1.9M
Uniting Mass Spectrometry and Glycoscience to Investigate Cancer BiologyK00CA212454 · NCI · STANFORD UNIVERSITY · PI RILEY, NICHOLAS M · 2018 to 2021
$331k
Howard Hughes Medical InstituteNCI NIH HHS K00 CA212454NCI NIH HHS R01 CA200423NCI NIH HHS U01 CA196387NCI NIH HHS U01 CA207702NCI NIH HHS U01 CA226051
6 · The paper itself

Abstract

Glycosylation is a prevalent, yet heterogeneous modification with a broad range of implications in molecular biology. This heterogeneity precludes enrichment strategies that can be universally beneficial for all glycan classes. Thus, choice of enrichment strategy has profound implications on experimental outcomes. Here we review common enrichment strategies used in modern mass spectrometry-based glycoproteomic experiments, including lectins and other affinity chromatographies, hydrophilic interaction chromatography and its derivatives, porous graphitic carbon, reversible and irreversible chemical coupling strategies, and chemical biology tools that often leverage bioorthogonal handles. Interest in glycoproteomics continues to surge as mass spectrometry instrumentation and software improve, so this review aims to help equip researchers with the necessary information to choose appropriate enrichment strategies that best complement these efforts.

Indexed as

AnimalsChromatographyGlycomicsGlycopeptidesGlycoproteinsGlycoside HydrolasesGraphiteHumansLectinsMass SpectrometryProteomicsGlycopeptidesGlycoproteinsGlycoside HydrolasesGraphiteLectinsaffinity chromatographychemical biologyenrichmentglycopeptidesglycoproteomicsGlycosylationhydrophilic interaction chromatography (HILIC)lectinsmass spectrometrystrong anion exchange electrostatic repulsion hydrophilic interaction chromatography (SAX-ERLIC)

Identifiers

PMID33583771
PMCPMC8724846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.